67
Growth Score
pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
794683
Iceni® Pharmaceuticals is a develops cancer therapies, specialising in repurposing and reformulating existing drugs for new indications.
- Rhys Roberts: Director
- John March: CEO
About the Company
Iceni® Pharmaceuticals develops cancer therapies, specialising in repurposing and reformulating existing drugs for new indications. Using this strategy, much of the cost and risk surrounding the drug development process can be reduced. Patients should benefit from more rapid availability of new treatments since they have already been through
extensive clinical trials and their safety profiles are already well established. The benefit to investors and licensees is a de-risked development process, since manufacture (CMC), toxicity and regulatory affairs are already well-characterised.
